JP2004519500A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519500A5
JP2004519500A5 JP2002573016A JP2002573016A JP2004519500A5 JP 2004519500 A5 JP2004519500 A5 JP 2004519500A5 JP 2002573016 A JP2002573016 A JP 2002573016A JP 2002573016 A JP2002573016 A JP 2002573016A JP 2004519500 A5 JP2004519500 A5 JP 2004519500A5
Authority
JP
Japan
Prior art keywords
htp
hydroxytryptophan
serotonin
tryptophan
cell growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002573016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519500A (ja
Filing date
Publication date
Priority claimed from DE10112882A external-priority patent/DE10112882A1/de
Application filed filed Critical
Publication of JP2004519500A publication Critical patent/JP2004519500A/ja
Publication of JP2004519500A5 publication Critical patent/JP2004519500A5/ja
Withdrawn legal-status Critical Current

Links

JP2002573016A 2001-03-15 2002-03-15 セロトニン生成腫瘍の特異的細胞増殖抑制性治療に関するトリプトファン誘導体の使用法 Withdrawn JP2004519500A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10112882A DE10112882A1 (de) 2001-03-15 2001-03-15 Verwendung von Tryptophan-Derivaten zur spezifischen zytostatischen Behandlung von Serotonin-produzierenden Tumoren
PCT/DE2002/000959 WO2002074309A2 (de) 2001-03-15 2002-03-15 Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren

Publications (2)

Publication Number Publication Date
JP2004519500A JP2004519500A (ja) 2004-07-02
JP2004519500A5 true JP2004519500A5 (https=) 2005-12-22

Family

ID=7677818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002573016A Withdrawn JP2004519500A (ja) 2001-03-15 2002-03-15 セロトニン生成腫瘍の特異的細胞増殖抑制性治療に関するトリプトファン誘導体の使用法

Country Status (7)

Country Link
US (2) US20040097576A1 (https=)
EP (1) EP1368027B1 (https=)
JP (1) JP2004519500A (https=)
AT (1) ATE272400T1 (https=)
DE (2) DE10112882A1 (https=)
ES (1) ES2225789T3 (https=)
WO (1) WO2002074309A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10043124A1 (de) * 2000-08-31 2002-03-14 Max Delbrueck Centrum Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase
GB2409048B (en) 2003-12-09 2007-07-11 Peter Steven Robertson Electricity metering
US20060264178A1 (en) * 2005-05-20 2006-11-23 Noble Gayle L Wireless diagnostic systems
CN109912489B (zh) * 2019-03-08 2022-05-13 哈尔滨商业大学 非活化烯烃烷基化合成2,3-二氢色胺类化合物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2236876C3 (de) * 1971-08-19 1981-02-12 Ajinomoto Co., Inc., Tokio N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
US4183858A (en) * 1977-07-01 1980-01-15 Merrell Toraude Et Compagnie α-Vinyl tryptophanes
DE3519687A1 (de) * 1985-06-01 1986-12-04 Veit Arend Aminosaeuren enthaltendes arzneimittel
US5631281A (en) * 1989-06-29 1997-05-20 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives
US6124263A (en) * 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
WO2003030907A1 (en) * 2001-10-09 2003-04-17 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto

Similar Documents

Publication Publication Date Title
RU2365372C2 (ru) Циклические ингибиторы протеинтирозинкиназ
Qiu et al. SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
CN103570725B (zh) 哌嗪并三唑类化合物及其制备方法和用途
Remke et al. Medulloblastoma molecular dissection: the way toward targeted therapy
TW200637849A (en) Kinase inhibitors
Gooskens et al. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP)
JP2004504347A5 (https=)
CA2417652A1 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
WO2005013800A3 (en) Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity
JP2009530392A5 (https=)
AU2001295482A1 (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
MX2007003104A (es) Nuevos derivados de ftalazinona, como inhibidores de cinasa aurora-a.
JP2005517657A5 (https=)
Lyu et al. Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
WO2004108664A3 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
JP2011516426A5 (https=)
Charidemou et al. Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview
CA2884832C (en) Means and method for treating solid tumours
JP2002510667A5 (https=)
JP2004519500A5 (https=)
NO20044573L (no) Farmasoytisk sammensetning omfattende arsenitt for behandling av malignhet
WO2022047288A9 (en) Methods of treating cancer
US20070299128A1 (en) Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors
SI1565176T1 (sl) Sredstvo, ki ima unicujoc ucinek na maligne tumorje, in postopek za njegovo pripravo
Matsui et al. Pharmacology of intraperitoneal CPT-11